Non-small-cell lung cancer (NSCLC) is any kind of epithelial lung cancer other than small cell lung cancer (SCLC). The most common kinds of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, although there are numerous more types that occur less frequently, and all types can have uncommon histologic variations.
The following factors may raise a person’s risk of developing NSCLC:
The following are the most common lung cancer – Non-Small Cell symptoms and signs :
Radiation Therapy (laser therapy) for Non-Small Cell Lung Cancer has proved to be one of the most suitable treatments.
To elaborate more, The laser activates the light-sensitive medication within cancer cells, assisting in their destruction. Several days later, the dead cells are occasionally removed using a bronchoscope.
Of note, however, the perfect execution of such a sensitive task necessitates a proper, accurate and highly professional laser machine.
In this line, the FDA LASER-1.2A Portable Surgery 810nm Diode Laser System is one of the most recommended equipment among surgeons due to its excellent efficacy in treating SCLC in particular.
To explain in more detail, this device’s blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm (the high-level laser radiation needed), the machine performs better and gentler cutting, even at lower power.
Accordingly, its improved cutting performance makes it ideally suited to all surgical applications, particularly for cancer-related issues.
What also makes the SLASER-1.2A highly appreciated and recommended by surgeons is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.
To further improve the treatment, the device is supported with a fiber guide laser. That is, it is compatible with various endoscopic uses. Also, these special fibers are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.
With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly address SCLC issues. That is highly attributed to the fact that the LASER-1.2 A uses infrared wavelengths and ultra-blue light to ensure high-level performance. This, in return, is also estimated to reduce the thermal damage and its peculiar interaction with haemoglobin.
Due to all these features, the LASER-1.2 A guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
The most prevalent kind of lung cancer is non-small-cell lung cancer (NSCLC), which accounts for around 85 percent of all occurrences. NSCLC is characterized by uncontrolled cell proliferation in lung tissue. These cells can develop tumors and spread to other parts of the body, posing a threat to one’s life. Fortunately, laser treatment has steadily been developed to identify and cure this problem, particularly because it has proven to be an effective supplement to cancer surgery in particular.
On this premise, we endeavored to explain the advantages of laser treatment, specifically the efficiency of LASER-1.2 A as a surgical laser device capable of effectively treating NSCLC issues.
Reference: Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.